NCT01587365View on ClinicalTrials.gov

Single Ascending Dose Safety Study of BMS-962476 in Healthy Subjects and Patients With Elevated Cholesterol on Statins

PHASE1CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Atherosclerosis
Interventions
BIOLOGICAL

BMS-962476

BIOLOGICAL

Placebo matching with BMS-962476

Trial Locations (1)

45227

Metabolic And Atherosclerosis Research Center/ Medpace Clinical Pharmacology, Cincinnati

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY